World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
61
Citations
18884
World Ranking
2951
National Ranking
1174

Patrizia Farci publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Patrizia Farci sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 186 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Patrizia Farci D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Patrizia Farci sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 61 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Patrizia Farci is affiliated with the National Institutes of Health in the United States and specializes in medical research with a focus on hepatology, epidemiology, infectious diseases, molecular biology, and oncology. Their work primarily revolves around liver diseases and viral hepatitis.

Farci's frequent co-authors include Ronald E. Engle, Hanh Nguyen, Harvey J. Alter, Zhaochun Chen, and Fausto Zamboni. These collaborations have contributed to a range of research efforts in liver-related viral infections and associated clinical outcomes.

The scientist has contributed extensively to various academic journals. Notable publication venues include:

  • PLoS Pathogens (3 publications)
  • Proceedings of the National Academy of Sciences (2 publications)
  • Journal of Viral Hepatitis (2 publications)
  • Journal of Hepatology (1 publication)
  • Nature Reviews Gastroenterology & Hepatology (1 publication)

Farci's research covers a variety of topics with significant emphasis on hepatitis viruses and liver conditions. Main topics addressed in their publications include:

  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Liver Disease Diagnosis and Treatment
  • Hepatitis Viruses Studies and Epidemiology
  • Liver Disease and Transplantation
  • Viral Gastroenteritis Research and Epidemiology
  • COVID-19 Clinical Research Studies

Recent publications by Farci include the following papers:

  • "EASL Clinical Practice Guidelines on hepatitis delta virus," 2023, Journal of Hepatology
  • "A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook," 2022, Nature Reviews Gastroenterology & Hepatology
  • "Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis," 2021, Proceedings of the National Academy of Sciences
  • "Hepatitis D Virus and Hepatocellular Carcinoma," 2021, Viruses
  • "Endpoints and New Options for Treatment of Chronic Hepatitis D," 2021, Hepatology

Best Publications

  • Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

    Patrick Marcellin;George K.K. Lau;Ferruccio Bonino;Patrizia Farci

  • The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

    Patrizia Farci;Atsushi Shimoda;Alessandra Coiana;Giacomo Diaz

  • Lack of protective immunity against reinfection with hepatitis C virus

    Patrizia Farci;Harvey J. Alter;Sugantha Govindarajan;Doris C. Wong

  • Prevention of Hepatitis C Virus Infection in Chimpanzees by Hyperimmune Serum against the Hypervariable Region 1 of the Envelope 2 Protein

    Patrizia Farci;Atsushi Shimoda;Doris Wong;Teresa Cabezon

  • A Long-Term Study of Hepatitis C Virus Replication in Non-A, Non-B Hepatitis

    Patrizia Farci;Harvey J. Alter;Doris Wong;Roger H. Miller

  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362].

    Patrizia Farci

  • Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B

    Maurizia Rossana Brunetto;Francesco Moriconi;Ferruccio Bonino;George K. K. Lau

  • Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.

    Patrizia Farci;Harvey J. Alter;Doris C. Wong;Roger H. Miller

  • INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B

    Antonina Smedile;Giorgio Verme;Antonietta Cargnel;Pietro Dentico

  • Chronic Hepatitis in Carriers of Hepatitis B Surface Antigen, with Intrahepatic Expression of the Delta Antigen: An Active and Progressive Disease Unresponsive to Immunosuppressive Treatment

    Mario Rizzetto;Giorgio Verme;Serafino Recchia;Ferruccio Bonino

  • Serological response to the hepatitis dSerological response to the hepatitis delta virus in hepatitis D.

    M Aragona;S Macagno;F Caredda;O Crivelli

  • Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a

    Patrick Marcellin;Ferruccio Bonino;George K.K. Lau;Patrizia Farci

  • Treatment of Chronic Hepatitis D with Interferon Alfa-2a

    Farci P;Mandas A;Coiana A;Lai Me

  • Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.

    P. Lusso;F. Cocchi;C. Balotta;P. D. Markham

  • Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

    M.E. Lai;A.P. Mazzoleni;A. Balestrieri;F. Argiolu

  • Long-term benefit of interferon α therapy of chronic hepatitis D: regression of advanced hepatic fibrosis

    Patrizia Farci;Tania Roskams;Luchino Chessa;Giovanna Peddis

  • Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.

    Ferruccio Bonino;P Marcellin;Gk Lau;S Hadziyannis

  • Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.

    Stefan Zeuzem;Moisés Diago;Edward Gane;K. Rajender Reddy

  • Delta hepatitis: an update

    Patrizia Farci

  • Clinical significance of hepatitis C virus genotypes and quasispecies.

    P Farci;R H Purcell

  • Serological response to the hepatitis delta virus in hepatitis D.

    M. Aragona;F. Caredda;C. Lavarini;P. Farci

Frequent Co-Authors

Robert H. Purcell
Robert H. Purcell National Institute of Allergy and Infectious Diseases
Ronald E. Engle
Ronald E. Engle National Institute of Allergy and Infectious Diseases
Harvey J. Alter
Harvey J. Alter National Institutes of Health
Sugantha Govindarajan
Sugantha Govindarajan University of Southern California
Ferruccio Bonino
Ferruccio Bonino National Research Council (CNR)
David E. Kleiner
David E. Kleiner National Institutes of Health
Xiaoping Su
Xiaoping Su The University of Texas MD Anderson Cancer Center
Jens Bukh
Jens Bukh University of Copenhagen
Mario Rizzetto
Mario Rizzetto University of Turin
Xifeng Wu
Xifeng Wu Zhejiang University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Microbiology, exploring related fields like health information management can open diverse career opportunities. Pursuing a master in health information management salary often reflects the growing demand for professionals who can bridge healthcare and data management. This degree offers competitive salaries and dynamic career paths in healthcare administration.

When selecting programs, accreditation matters. The best online health information management degree cahiim accredited options ensure that your education meets industry standards, preparing you effectively for certification and employment in this growing field.

For those seeking faster entry into the healthcare sector, certificate programs like the best fastest online medical billing and coding certificate programs provide practical skills that are in high demand. These programs complement microbiology knowledge by facilitating administrative roles within medical facilities.

Moreover, healthcare education continues to evolve, with many flexible options available. Interested learners can explore what medical degrees can i get online to find accredited programs that fit their schedules while advancing their medical and scientific expertise.

Best Scientists Citing Patrizia Farci

Trending Scientists

Recently Published Articles